X0306 4 2014-06-24 0001484478 Furiex Pharmaceuticals, Inc. FURX 0001590795 Patel Sailash C/O FURIEX PHARMACEUTICALS, INC., 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560 1 Chief Financial Officer Common Stock 2014-06-24 4 M 0 32928 9.11 A 59372 D Common Stock 2014-06-24 4 S 0 32928 104 D 26444 D Stock Options (to buy) 9.11 2014-06-24 4 M 0 32928 0 D 2020-06-17 Common Stock 32928 26360 D Stock Options (to buy) 15.0000 2021-05-09 Common Stock 20000 20000 D Stock Options (to buy) 13.1600 2021-10-03 Common Stock 29644 29644 D Stock Options (to buy) 17.8000 2022-02-24 Common Stock 8294 8294 D All options became 100% vested on June 11, 2014 in connection with the Agreement and Plan of Merger dated as of April 27, 2014 by and among Forest Laboratories, Inc., Royal Empress, Inc. and Furiex Pharmaceuticals, Inc. /s/ Donald R. Reynolds, by Power of Attorney 2014-06-26